Data / Form D filings / Intercure Ltd.
Intercure Ltd.: Form D filing
Intercure Ltd., a pharmaceuticals company in Hertzliya, Israel, filed a Form D with the SEC in 2026. The latest, on August 19, 2026, reports an offering of no set size with nothing sold yet to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 85 MEDINAT HA-YEHUDIM ST., Hertzliya, Israel, 46766
- Phone
- 972-77-460-5012
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1857030
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | New notice | Indefinite | $0 | 15 | Jun 15, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alexander Rabinovich | Executive Officer, Director | Chief Executive Officer and Chairman of the Board of Directors |
| David Salton | Director | |
| Lennie Michelson Grinbaum | Director | |
| Gideon Hirschfeld | Director | |
| Amos Cohen | Executive Officer | Chief Financial Officer |
Every Form D from the week of Aug 17, 2026 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Intercure Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.